Publicly filing life insurers increased their CLO holdings by $14 billion during the 2024 calendar year, according to data provided to Octus, formerly Reorg, by New Debt Exchange. The asset class ...

Implus Corp. owns 16 active lifestyle accessory brands (including SKLZ, TriggerPoint, Balega, Harbinger, RockTape, Sof Sole and Spenco) sold across more than 60,000 retail outlets in 60 countries.

Mark Walter’s business empire spans life insurers, sports teams, Guggenheim Investments and a slice of Carvana. This past month, nearly all of it came under scrutiny at once. Guggenheim’s first lien ...

This blog covers three rebuilds of the system that reads dataroom notifications, and how the sharpest version yet earns its accuracy by handing the model less to do. “Every day, financial datarooms ...

After the August lull, investors can expect a torrent of issuance to start the post-Labor Day calendar. Financings backing buyouts and M&A remains muted, but banks are rushing to market with billions ...

The United Site Services debtors filed a motion tonight seeking approval of a backstop commitment agreement with an ad hoc lender group that would fully guarantee a $480 million equity rights offering ...

The article discusses the use of PIK toggles in European private credit deals, highlighting that while they appear in most deals, they are rarely utilized due to their limited impact on IRR and high ...

Explore the latest earnings analysis of Grupo Antolin post-recapitalization and its implications for future negotiations.

Eiffel Investment Group hires a portfolio manager from BNP Paribas AM. Discover the latest moves in the CLO management sector.

The primary market was muted again this week as market participants continued to grapple with AI’s impact on the credit markets and monitored geopolitical developments. Octus tracked just seven loans ...

When you’re the nation’s largest public pension fund, any move you make is inevitably scrutinized by the market, especially when it seems to be “going against the current thinking,” said Marcie Frost, ...

U.K. private equity firm Exponent is closing in on acquiring Irish pharmaceutical company Chanelle Pharma in a deal worth more than €300 million, according to The Times. Michael Burke, who founded ...